CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for A Plus Biotechnology Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

A Plus Biotechnology Co Ltd
3F, No.21, Qiaohe Road, Zhonghe District
Phone: +886 222499222p:+886 222499222 NEW TAIPEI, 235  Taiwan Ticker: 69186918
Business Summary
A Plus Biotechnology Co Ltd is a Taiwan-based company mainly engaged in the manufacture and wholesale of trauma and orthopedic products, proxy products and other medical equipment. Trauma products provide stable fixation of various fracture types of bones in various parts until bone healing, including orthopedic internal fixation bone plates, bone nails, bone needles, intramedullary nails, cables, and external fixators. Orthopedic products are used to assist precise correction and fixation, including knee arthritis correction systems, hallux valgus correction systems, and additive manufacturing surgical guide plates. Proxy products include artificial bone replacement, cartilage repair, and cell therapy. Spinal products are used to fix the spine and support the intervertebral height, including spinal fixation systems and spinal intervertebral fusion devices. The products are mainly sold domestically and exported to mainland China, Asia, the United States, and Africa.
(Source: N-30D)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202412/31/2023-----

Industries
SIC Code Description
3841 Surgical and medical instruments and apparatus
3842 Orthopedic, prosthetic, and surgical appliances and supplies

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board SimingLi 9/1/2024
Head of Finance & Accounting, Corporate Governance Officer Pei-chunKo 3/29/2024 12/13/2023

General Information
Outstanding Shares: 30,164,000 (As of 6/30/2024)
Stock Exchange: TPO
Fax Number: +886 222437711


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Monday, December 2, 2024